Semaglutide is a synthetic research peptide studied for its activity as a GLP-1 receptor agonist — one of the most extensively documented compounds in incretin pharmacology, with a clinical trial record (the STEP and SUSTAIN programs) that spans over a decade. Developed originally by Novo Nordisk, Semaglutide is the reference point most researchers use when evaluating newer dual- and triple-agonist peptides such as GLP-1TRZ and GLP-3RTA. Helix Bio supplies Semaglutide as a lyophilized powder intended strictly for laboratory and preclinical research, manufactured to a high-purity standard and backed by third-party verification. It is not intended for human consumption, diagnostic use, or any therapeutic application, and it is a separate product from FDA-approved branded medications.
HPLC certified
Independent analysis
Highest standard
Full traceability
Semaglutide is studied as a long-acting GLP-1 receptor agonist — a peptide analog engineered for extended receptor engagement compared with earlier compounds like liraglutide. It's the single-receptor reference compound in a research field that has since expanded to dual agonists (GLP-1TRZ, which adds GIP receptor activity) and triple agonists (GLP-3RTA, which adds glucagon receptor activity on top of that). Because Semaglutide has the deepest clinical trial history of the three, it's frequently used as the comparison baseline in mechanism-of-action and metabolic outcome research.
Helix Bio's Semaglutide is supplied as a lyophilized (freeze-dried) powder — a synthetic peptide manufactured under controlled laboratory conditions. Lyophilization extends shelf stability prior to reconstitution, which is useful for labs running studies over an extended timeline rather than using a full vial at once.
This product exists to support in vitro and preclinical laboratory research only. It's manufactured, labeled, and sold for research use only (RUO) — not for human or veterinary use, not for diagnostic procedures, and not for compounding. It's intended for researchers studying GLP-1 receptor pharmacology, incretin signaling, or metabolic research models.
Semaglutide research isn't new, but that's exactly what makes sourcing quality material worth getting right — there's a large body of published literature to compare your results against, and a bad batch undermines that comparison before you've started. Helix Bio manufactures its Semaglutide domestically, backs every batch with purity testing, and issues documentation so researchers can evaluate what they're working with before it reaches the bench. If your protocol calls for a well-characterized single-receptor GLP-1 agonist as a baseline or comparator compound, that's what this listing is built around.
This product is not intended for individual consumers seeking to use it outside a research setting, and it is not a substitute for any FDA-approved medication.
| Field | Detail |
|---|---|
| Product Name | Semaglutide |
| Category | Research Peptide — GLP-1 Receptor Agonist |
| Form | Lyophilized powder |
| Purity | High-purity, batch-verified — see current lot's Certificate of Analysis for the exact figure |
| Appearance | White to off-white lyophilized powder |
| Storage (unreconstituted) | Store frozen, protected from light |
| Packaging | Sealed glass vial, tamper-evident packaging |
| Research Use | Laboratory / in vitro / preclinical research only — not for human or animal use |
| Manufacturer | Domestically produced (USA) |
| Quality | Third-party purity testing performed per batch |
| Lot Testing | HPLC and mass spectrometry verification |
| Country of Origin | United States |
Semaglutide is studied across a few overlapping areas of metabolic and endocrine research:
Semaglutide's clinical trial record is the most extensive of the GLP-1 class, built primarily on Novo Nordisk's SUSTAIN program (type 2 diabetes) and STEP program (weight management), with cardiovascular outcomes data published alongside them. Semaglutide is also the active ingredient in several FDA-approved branded prescription medications. The material Helix Bio sells is a separate, research-grade product — it is manufactured and labeled for laboratory research only and is not the same product, formulation, or delivery system as any approved drug. Nothing here should be read as equivalent to, a substitute for, or off-label guidance regarding any approved medication.
Purity is the first thing serious researchers check, and it's the first thing worth being transparent about. Helix Bio's Semaglutide is manufactured in a controlled laboratory environment and tested by a third party using high-performance liquid chromatography (HPLC) and mass spectrometry — the two standard methods for confirming peptide identity and purity in the research supply chain. Each batch is issued its own Certificate of Analysis (COA), so purity isn't something you have to take on faith; you can review the documentation for the specific lot you receive. If a vendor can't produce a COA for the batch in your hand, that's worth treating as a red flag — for Semaglutide or any research peptide.
Handling in our facility follows accepted good manufacturing practice for research-use compounds: peptides are processed to limit contamination, packaged in sealed, tamper-evident vials, and shipped in a way that protects the lyophilized powder from temperature swings and light exposure during transit.
Semaglutide ships in a sealed, tamper-evident vial packaged to protect the lyophilized powder in transit. Because peptide stability can be affected by heat, orders are packed with insulation appropriate to the season and route. Exact carriers, transit times, and packaging materials can vary by order — check Helix Bio's shipping policy page for current specifics before ordering.
Semaglutide sold by Helix Bio is intended strictly for in vitro laboratory and preclinical research use. It is not a drug, dietary supplement, cosmetic, or food product, and this specific research-grade material is not approved by the FDA or any regulatory body for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease or condition. It is a distinct product from any FDA-approved Semaglutide-containing medication and must not be treated as interchangeable with, or a substitute for, an approved prescription drug. This product must not be administered to humans or animals outside of a properly licensed research facility. Nothing on this page constitutes medical advice, and no statement here should be interpreted as a therapeutic or health claim. By purchasing this product, the buyer confirms they are a qualified researcher, laboratory, or institution acquiring it for lawful research purposes only, and accepts full responsibility for compliance with all applicable local, state, and federal regulations governing research chemicals.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
What bacteriostatic water contains, how it differs from sterile water and saline, where the 28-day opened-vial figure comes from, and what a COA can show.
Do you need a prescription for peptides? It depends on the category. See which peptides need one, which do not, and the dated 2026 FDA rules that apply.
The complete 2026 list of FDA-approved peptides: 47 drugs by category and approval year, which popular peptides are not approved, and pipeline to watch.
